Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial

Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial

Background: R-CHOP with or without radiotherapy is the standard treatment for limited-stage diffuse large B-cell lymphoma (DLBCL). To prevent overtreatment, we assessed whether four cycles of CHOP plus six applications of rituximab was adequate with negative interim PET/CT and the role of consolidat...

Full description

Bibliographic Details
Main Authors: Cao, J. (Author), Gu, J.J (Author), Guo, Y. (Author), Hong, X. (Author), Ji, D. (Author), Jin, J. (Author), Liu, Y. (Author), Lv, F. (Author), Xia, Z. (Author), Xue, K. (Author), Zhang, Q. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Diffuse large B-cell lymphoma
Limited stage
Positron emission tomography
Prognosis
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items